Erythromycin-based Drug Library (Proof-of-Concept)

About kez.biosolutions

kez.biosolutions is an early-stage biotech leveraging synthetic biology to revolutionize polyketide engineering. Its kezbio platform utilizes proprietary enzyme technology and substrates to precisely modify polyketide scaffolds, aiming to generate novel drug candidates against resistant pathogens and for other therapeutic applications. Currently in a proof-of-concept phase with an erythromycin-based library, the company plans to offer customized strain and substrate packages to partners. It operates as a pre-revenue, private entity focused on platform development and future collaborative R&D.

Therapeutic Areas

Other Antimicrobial Resistance Drugs